Open Collections

Development and characterization of Paclitaxel loaded polymeric films based on polysaccharides-graft-poly (E-caprolactone) for the prevention of surgical adhesions

University of British Columbia

Novel amphiphilic graft copolymers with hydrophilic hydroxypropylcellulose (HPC) and dextrans (Dx) as main chains and hydrophobic poly(ε-caprolactone) (PCL) as side chains were synthesized and characterized. Paclitaxel loaded polymeric films based on these graft copolymers were developed and characterized for the prevention of surgical adhesions. Hydroxypropylcellulose-graft-poly(s-caprolactone) (HPC-g-PCL) and dextrangraft- poly(ε -caprolactone) (Dx-g-PCL) were synthesized via a "graft from" process, in which the PCL side chains were formed by a ring-opening polymerization of scaprolactone (CL) initiated by the hydroxyl groups on the main chains of HPC or dextrans. HPC-g-PCL with a molar substitution of CL (MSCL) in the range of 8.6 to 10.1 was synthesized by bulk polymerization without using any catalyst. Dx-g-PCLs were synthesized by solution polymerization using dimethyl sulfoxide as a solvent and stannous 2-ethylhexanoate as a catalyst. Dextrans with two different molecular weights, 70,000 (Dx70) and 500,000 (Dx500), were used as the main chains and the MSCL was determined to be in the range of 1.2 to 1.3. The films of the copolymers with or without paclitaxel were cast from tetrahydrofuran (THF) solutions. Both paclitaxel and the graft copolymers could be readily dissolved in THF and homogenous film formulations with paclitaxel loading up to 10% (w/w) were obtained. Due to the higher MSCL of HPC-g-PCL, PCL-rich microcrystalline regions formed in the HPC-g-PCL films. Films of HPC-g-PCL were more hydrophobic than the Dx-g-PCL films and showed less water uptake and swelling. Controlled release of paclitaxel from the copolymer films was achieved. An increase in initial paclitaxel loading resulted in an increase in the release rate for all the copolymer films. At 1% paclitaxel loading, the release rate from the Dx-g-PCL films was significantly higher than from the HPC-g-PCL films due to increased swelling and therefore greater diffusion rate of paclitaxel in the Dx-g-PCL matrices. At loadings of 5% and 10%, crystallization of paclitaxel occurred in the Dx-g-PCL matrices during incubation in the release media. The onset of this crystallization event led to a reduction in paclitaxel release rate from the films. At 10% loading, release rates from the Dx-g- PCL and HPC-g-PCL films were similar. No significant degradation was detected after the HPC-g-PCL films were incubated in aqueous media at 37 °C for 3 months and this was considered unsuitable for a surgical adhesion formulation. Dx-g-PCL films with or without paclitaxel were evaluated in rat models of surgical adhesions. The films were biocompatible and showed good handling characteristics when being applied to a surgical site. In a rat cecal abrasion model, Dx500-g-PCL films with paclitaxel loadings of 0.1% and 0.5% significantly reduced adhesion formation. Dx500-g-PCL films with no paclitaxel showed a barrier effect and reduced the incidence of adhesion formation.

Thesis/Dissertation

application/pdf

2009-11-13

For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.

http://hdl.handle.net/2429/14934

Pharmaceutical Sciences

University of British Columbia

UBCV

DSpace